Immunoglobulin supply for USK-1 PUM Szczecin
Original notice title
Poland – Immunoglobulins – Dostawa immunoglobulin dla USK-1 PUM w Szczecinie
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
45 / 100
Risk factors
No estimated value or framework maximum is disclosed. Bidders cannot assess the financial potential of the contract.
Attachment no. 2 (detailed description of subject) was not provided for analysis. Critical technical and quantity detai...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 3 lots
- Duration 12 MONTH
- Supply of immunoglobulins
- Two lots for drug programs B.17, B.62, B.67
Show full summary
This tender by Uniwersytecki Szpital Kliniczny nr 1 PUM w Szczecinie (Poland) is for the supply of immunoglobulins divided into 4 lots (packages). Two lots cover drug programs B.17, B.62, B.67; the other two cover substitution in indications other than drug programs. The award is 100% based on price. The tender is open, EU-funded, and requires electronic submission. No estimated value is provided. Detailed specifications are in attachment no. 2, which was not analyzed. The deadline for submission is 20 August 2026, 08:00 CEST.
Risks
No estimated value or framework maximum is disclosed. Bidders cannot assess the financial potential of the contract.
Attachment no. 2 (detailed description of subject) was not provided for analysis. Critical technical and quantity detai...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Maximum number of lots a tenderer can bid for: 4
- Maximum number of lots that can be awarded to a tenderer: 4
- Variants not allowed
Award Criteria
Lot 1
Lot 2
Lot 3
Lot 4
Buyer
Location
Szczecin, POL
Website
Buyer profile
Identifier
8522211119
Activity
Health
Lots (4)
LOT-0001
Package 1 - Drug program B.17, B.62, B.67
Supply of immunoglobulins for drug programs B.17, B.62, B.67. Detailed description in attachment no. 2 to SWZ.
Location
Duration
Category
Award Criteria
Deadline
Award details
100
Value note
Show original TED data
Original lot title
PAKIET NR 1 - Program lekowy - B.17, B.62, B.67
Original TED description
Szczegółowy opis przedmiotu zamówienia znajduje się w Załączniku nr 2 do SWZ
LOT-0002
Package 2 - Drug program B.17, B.62, B.67
Supply of immunoglobulins for drug programs B.17, B.62, B.67. Detailed description in attachment no. 2 to SWZ.
Location
Duration
Category
Award Criteria
Deadline
Award details
100
Value note
Show original TED data
Original lot title
PAKIET NR 2 -Program lekowy - B.17, B.62, B.67
Original TED description
Szczegółowy opis przedmiotu zamówienia znajduje się w Załączniku nr 2 do SWZ
LOT-0003
Package 3 - Immunoglobulin substitution in non-drug program indications
Supply of immunoglobulins for substitution in indications other than drug programs. Detailed description in attachment no. 2 to SWZ.
Location
Duration
Category
Award Criteria
Deadline
Award details
100
Value note
Show original TED data
Original lot title
PAKIET NR 3 - Lek - substytucja immunoglobulinami we wskazaniach innych niż w programach lekowych
Original TED description
Szczegółowy opis przedmiotu zamówienia znajduje się w Załączniku nr 2 do SWZ
LOT-0004
PAKIET NR 4 - Lek - substytucja immunoglobulinami we wskazaniach innych niż w programach lekowych
Szczegółowy opis przedmiotu zamówienia znajduje się w Załączniku nr 2 do SWZ
Location
Duration
Category
Award Criteria
Award details
100
Procurement Details
- Publication date
- 06 Jul 2026
- Languages
- Polish
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 465265-2026
Documents (1)
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
45 / 100
Risk factors
No estimated value or framework maximum is disclosed. Bidders cannot assess the financial potential of the contract.
Attachment no. 2 (detailed description of subject) was not provided for analysis. Critical technical and quantity detai...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications